2-Year U.S. Treasury Note Continuous Contract $ ... % 10-Year U.S. Treasury Note Continuous Contract $110.109 0.141 0.13% 30-Year U.S. Treasury Bond Continuous Contract $113.125 0.438 0.39% ...

Many market participants entered the year optimistic that the Trump 2.0 administration would herald a business-frien ...

Bay's AI tools streamline seller listings and enhance buyer searches, boosting efficiency and increasing inventory visibility ...

The S&P 500 and Nasdaq 100 indexes turned higher for the year on Tuesday, reversing multi-trillion dollar routs, as ...

RENEW Phase 2 trial evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) initiated with topline interim data expected ...

Finally, bucking the trend of the rallying market, they are all trading at least 30% below ... stock chart, with Ford shedding more than a quarter of its value over the past three years.

Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type ...

Resolution of CRL Manufacturing issues in progress - Type A meeting requested No clinical safety or efficacy concerns raised by FDA MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Miles ...

April 22, 2025--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster ... April 25-30, 2025 in Chicago ...

Company to Host Conference Call, May 13, 2025 at 4:30 p.m. ETSAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ ... a late breaking poster at this year’s Muscular ...

Reported Net Product Revenues of $20.9 million for the first quarter of 2025, a year-over-year increase of approximately 8% National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...